EVALUATION OF THE ARGYROPHILIC NUCLEOLAR ORGANIZER REGION, NUCLEAR-DNA CONTENT AND MEAN NUCLEAR-AREA IN TRANSITIONAL-CELL CARCINOMA OF BLADDER USING A QUANTITATIVE IMAGE ANALYZER
H. Shiina et al., EVALUATION OF THE ARGYROPHILIC NUCLEOLAR ORGANIZER REGION, NUCLEAR-DNA CONTENT AND MEAN NUCLEAR-AREA IN TRANSITIONAL-CELL CARCINOMA OF BLADDER USING A QUANTITATIVE IMAGE ANALYZER, European urology, 29(1), 1996, pp. 99-105
To search for reliable parameters that reflect the biological potentia
l of bladder cancer, the argyrophilic nucleolar organizer region (AgNO
R), nuclear DNA content and mean nuclear area (MNA) were studied in pa
raffin-embedded materials of 75 primary transitional cell carcinomas (
TCCs) using a quantitative image analyzer, and were also compared with
histological findings and prognosis. The AgNOR parameters studied wer
e the mean AgNOR count (C-AgNOR) and the percentage of cells exhibitin
g more than 4 AgNOR dots within nuclei (P-AgNOR), whereas the DNA para
meters were the 2c deviation index (2cDI) and 5c exceeding rate (5cER)
. These 5 parameters significantly correlated with the histological gr
ade (p < 0.0001, respectively). Similarly, these 5 parameters correlat
ed with the histological stage, but the correlation was higher in 2cDI
and ScER (p < 0.0001, respectively) in comparison with the AgNOR para
meters and MNA. Using univariate analysis, the prognostic relevance wa
s noted in all but P-AgNOR. The ScER value could discriminate histolog
ical grade-II tumors in relation to prognosis, whereas the remaining p
arameters could not. In addition, the significant difference between n
oninvasive and invasive tumors was noted in 2cDI and ScER (p < 0.05, r
espectively), but not in C-AgNOR, P-AgNOR and MNA. These results sugge
st that (i) 2cDI and ScER exhibit superiority over the AgNOR parameter
s and MNA in predicting survival, and (ii) in histological grade-II tu
mors, evaluation of the ScER value is most important when predicting s
urvival as well as judging the necessity for further aggressive treatm
ent in patients with TCCs of the bladder.